Item 7.01 Regulation FD Disclosure.
On August 20, 2020, OpGen, Inc. updated its corporate presentation, which it
made available on its website. A copy of the presentation is furnished as
Exhibit 99.1 to this report.
Item 8.01 Other Events.
On August 20, 2020, OpGen, Inc. issued a press release announcing its
subsidiary, Curetis GmbH, has obtained the CE mark certification in the European
Union for its SARS-CoV-2 test kit that tests for the detection of SARS-CoV-2,
the virus that causes COVID-19. A copy of the press release is attached hereto
as Exhibit 99.2 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Document
99.1 Corporate Presentation dated August 2020
99.2 Press Release issued by OpGen, Inc. dated August 20, 2020
The information included in Item 7.01 of this report and Exhibit 99.1 shall not
be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except as
expressly set forth by specific reference in such filing.
© Edgar Online, source Glimpses